RIYADH PHARMA – To work harder to meet health care needs, in order to lead the manufacture and supply of health care products in the Middle East region by providing a comprehensive range of high quality products and professional services, and to contribute towards the nation’s self-sufficiency in pharmaceutical needs.

Company highlights:

• In 1998, the plant was granted a Good Manufacturing Practice (GMP) license in the Kingdom of Saudi Arabia.
• The plant and its products have also been registered in several Arab countries, and a plan is in place to register them in Europe and in the US.
• The company employs state-of-the-art manufacturing facilities and advanced technology in every operational process:
  • Fully integrated, high speed production equipment from the world’s top pharmaceutical technology suppliers.
  • Digital systems for environment control and comprehensive quality assurance.
  • Process logic control systems and fully automated warehouse management system.
• To strengthen our technological platform, we have entered into agreements with world-class pharmaceutical organizations to transfer know-how and technology to our facilities, as well as supply raw materials and manufacturing components, e.g. MERCK Generics Group (Germany).
• Our broad portfolio of products covers: Prescription Medicines (Rx), Consumer Health Products (OTC), Hospital Antiseptics.
• Riyadh Pharma has been accredited by several world leading pharmaceutical companies. To produce some of their patent brands.
• Riyadh Pharma is one of the largest and fastest-growing companies in Saudi Arabia and in the Middle East.

Global healthcare brands represented by Riyadh Pharma:

• Merck (Germany)
• Smith+Nephew (UK)
• Janssen-Cilag (Belgium and Switzerland)
• Norgine (UK)

Website: www.riyadhpharma.com